Misled by the Morning "Fasting" Plasma Glucose

J Diabetes Sci Technol. 2015 May 13;9(6):1342-5. doi: 10.1177/1932296815586425.

Abstract

Because of its ease and simplicity of its measurement, the morning fasting plasma glucose (FPG), has been as used a surrogate marker for the entire basal day when titrating once-nightly basal insulin. Common in obese insulin-treated patients with type 2 diabetes, late and large evening meals elevate the FPG. This has led to dosing of basal insulin well beyond the basal requirements and contributes to hypoglycemia and weight gain seen with this therapy. It is recommended that during basal insulin titration, the evening meal be limited and hypoglycemia be monitored early in the morning, that bewitching time when the "peakless" basal insulin's action is peaking and the predawn phenomenon insulin sensitivity is higher.

Keywords: basal insulin; fasting morning glucose; hypoglycemia; insulin; weight gain.

MeSH terms

  • Biomarkers / blood
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism*
  • Circadian Rhythm*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Drug Dosage Calculations
  • Fasting / blood*
  • Humans
  • Hypoglycemia / blood
  • Hypoglycemia / chemically induced
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects
  • Predictive Value of Tests
  • Reproducibility of Results
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Weight Gain / drug effects

Substances

  • Biomarkers
  • Blood Glucose
  • Hypoglycemic Agents